Regulatory Approvals

Recon DL is the first mammography technology to combine deep learning with iterative reconstruction methods to enhance digital breast tomosynthesis (DBT) image quality.

Eydenzelt will be available in both pre-filled syringe and vial formats, and it is approved for all the same uses as the original Eylea treatment.

Each year in the United States, more than 20 million abdomen-pelvis CT scans are performed, and the volume continues to increase.

Itvisma works by delivering a functional copy of the survival motor neuron 1 (SMN1) gene through a single, fixed-dose intrathecal injection.